STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Companies Micro-Cap

IGC Pharma’s IGC-AD1 Shows Promising Results in Alzheimer’s Agitation Trial

byLiliana Vida
March 20, 2024
in Micro-Cap, Pharmaceuticals
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Interim Analysis Reveals Statistically Significant Reduction in Agitation Levels

IGC Pharma (IGC) has unveiled encouraging findings from its ongoing Phase 2 trial of IGC-AD1 for Agitation in Dementia from Alzheimer’s Disease (AAD). With Alzheimer’s affecting an estimated 6.7 million Americans in 2023, addressing agitation is crucial, as up to 76% of patients experience this symptom.

The interim analysis showcases a notable reduction in agitation among Alzheimer’s patients treated with IGC-AD1 compared to those receiving a placebo. Using the Cohen Mansfield Agitation Inventory (CMAI) scale, patients exhibited significantly lower agitation scores as early as week two of the trial.

Key findings include a Cohen’s d effect size of 0.66 at the primary outcome assessment at week six, indicating the superiority of IGC-AD1 over placebo. Additionally, the LS mean difference between active and placebo was -10.45, with a p-value of 0.037.

These promising results underscore the potential of IGC-AD1 to improve patient outcomes in Alzheimer’s-related agitation. Ram Mukunda, CEO of IGC Pharma, expressed confidence in the clinical profile of IGC-AD1, signaling its potential to drive shareholder value pending further trials.

Read original press release:here

You might like this article:XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction

Previous Post

Volkswagen Partners with Mobileye to Pioneer Autonomous Driving

Next Post

Alibaba Raises $317 Million from XPeng Share Sale

Related Posts

EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders

byLiliana Vida
June 30, 2025
0

CEO Erez Aminov on Breakthrough Drug Candidates, Strategic Acquisitions, and the Vision Behind MIRA’s Innovation-Driven Pipeline MIRA Pharmaceuticals (NASDAQ: MIRA),...

MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog

byLuca Blaumann
June 18, 2025
0

Peer-reviewed journal spotlights differentiated pharmacology and therapeutic promise for neuropathic pain MIRA Pharmaceuticals (MIRA), a clinical-stage biotech firm focused on...

trading-chart-2

Telomir Pharmaceuticals Reports Breakthrough Anti-Aging Results in Preclinical Werner Syndrome Model

byLuca Blaumann
June 5, 2025
0

Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model Telomir Pharmaceuticals (TELO), a...

Next Post
mobile-phone

Alibaba Raises $317 Million from XPeng Share Sale

Latest News

KULR Boosts Bitcoin Holdings to Over 1,000 BTC, Reports 291% Year-to-Date BTC Yield

Delta Reinstates 2025 Profit Outlook, But Summer Travel Outlook Lifts Shares

Uber Rides High on AV Partnerships and Strategic Momentum

Nvidia Becomes First Public Company to Top $4 Trillion in Market Value

Trump Executive Order Deals Blow to U.S. Solar Sector

Based on Your Interest

trading-chart
Large-Cap

IBM Launches Power11 Chips to Boost AI Efficiency and Data Center Reliability

July 8, 2025
bitcoin-1
Bitcoin

KULR Technology Secures $20 Million Bitcoin-Backed Credit Facility from Coinbase

July 8, 2025
semiconductor-7
Large-Cap

Citi Boosts Nvidia Target on Soaring Global AI Demand

July 7, 2025

Recommended

Biotechnology

Regencell Bioscience’s Stock Whipsaws Again Amid 17,000% Surge in 2025

July 7, 2025
Cybersecurity

CrowdStrike Hits Record High After Wedbush Declares It Cybersecurity’s “Gold Standard”

July 3, 2025
Large-Cap

OpenAI Secures 4.5 GW of Data Center Power From Oracle in Record-Breaking Deal

July 3, 2025
Large-Cap

Footwear Stocks Rise After Trump Announces Vietnam Trade Deal

July 2, 2025
Altcoins

Circle Applies for U.S. Trust Bank Charter to Strengthen Stablecoin Strategy

July 1, 2025
Stoxpo

Follow us on social media:

Highlights

  • KULR Boosts Bitcoin Holdings to Over 1,000 BTC, Reports 291% Year-to-Date BTC Yield
  • Delta Reinstates 2025 Profit Outlook, But Summer Travel Outlook Lifts Shares
  • Uber Rides High on AV Partnerships and Strategic Momentum
  • Nvidia Becomes First Public Company to Top $4 Trillion in Market Value
  • Trump Executive Order Deals Blow to U.S. Solar Sector

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

KULR Boosts Bitcoin Holdings to Over 1,000 BTC, Reports 291% Year-to-Date BTC Yield

July 10, 2025
airplane

Delta Reinstates 2025 Profit Outlook, But Summer Travel Outlook Lifts Shares

July 10, 2025

Uber Rides High on AV Partnerships and Strategic Momentum

July 9, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?